Electronic health record design and implementation for pharmacogenomics: a local perspective
JF Peterson, E Bowton, JR Field, M Beller… - Genetics in …, 2013 - nature.com
Purpose: The design of electronic health records to translate genomic medicine into clinical
care is crucial to successful introduction of new genomic services, yet there are few …
care is crucial to successful introduction of new genomic services, yet there are few …
Evaluation of research in biomedical ontologies
R Hoehndorf, M Dumontier… - Briefings in …, 2013 - academic.oup.com
Ontologies are now pervasive in biomedicine, where they serve as a means to standardize
terminology, to enable access to domain knowledge, to verify data consistency and to …
terminology, to enable access to domain knowledge, to verify data consistency and to …
API-centric linked data integration: The open PHACTS discovery platform case study
Data integration is a key challenge faced in pharmacology where there are numerous
heterogeneous databases spanning multiple domains (eg chemistry and biology). To …
heterogeneous databases spanning multiple domains (eg chemistry and biology). To …
Applying linked data approaches to pharmacology: Architectural decisions and implementation
The discovery of new medicines requires pharmacologists to interact with a number of
information sources ranging from tabular data to scientific papers, and other specialized …
information sources ranging from tabular data to scientific papers, and other specialized …
[HTML][HTML] A method for structuring complex clinical knowledge and its representational formalisms to support composite knowledge interoperability in healthcare
Introduction The use and interoperability of clinical knowledge starts with the quality of the
formalism utilized to express medical expertise. However, a crucial challenge is that existing …
formalism utilized to express medical expertise. However, a crucial challenge is that existing …
Pharmacogenomics in the pocket of every patient? A prototype based on quick response codes
M Samwald, KP Adlassnig - Journal of the American Medical …, 2013 - academic.oup.com
A sizable fraction of patients experiences adverse drug events or lack of drug efficacy. A part
of this variability in drug response can be explained by genetic differences between patients …
of this variability in drug response can be explained by genetic differences between patients …
[HTML][HTML] Search and visualization of gene-drug-disease interactions for pharmacogenomics and precision medicine research using GeneDive
M Wong, P Previde, J Cole, B Thomas… - Journal of biomedical …, 2021 - Elsevier
Background Understanding the relationships between genes, drugs, and disease states is at
the core of pharmacogenomics. Two leading approaches for identifying these relationships …
the core of pharmacogenomics. Two leading approaches for identifying these relationships …
Leveraging a pharmacogenomics knowledgebase to formulate a drug response phenotype terminology for genomic medicine
Motivation Despite the increasing evidence of utility of genomic medicine in clinical practice,
systematically integrating genomic medicine information and knowledge into clinical …
systematically integrating genomic medicine information and knowledge into clinical …
Learning from biomedical linked data to suggest valid pharmacogenes
K Dalleau, Y Marzougui, S Da Silva, P Ringot… - Journal of biomedical …, 2017 - Springer
Background A standard task in pharmacogenomics research is identifying genes that may
be involved in drug response variability, ie, pharmacogenes. Because genomic experiments …
be involved in drug response variability, ie, pharmacogenes. Because genomic experiments …
Making data on essential pharmacogenes available for every patient everywhere: the Medicine Safety Code initiative
M Samwald, RR Freimuth - Pharmacogenomics, 2013 - Taylor & Francis
Even though pharmacogenetics holds great potential for improving the quality of pharmaco
therapy, there are several major barriers to the integration of pharmacogenetics data into rou …
therapy, there are several major barriers to the integration of pharmacogenetics data into rou …